ClearFlow provides PleuraFlow®, an active chest‑tube clearance system that continuously removes blood and clots from thoracic drainage catheters using a motor‑driven mechanism and real‑time pressure monitoring. The plug‑and‑play device integrates with standard chest‑tube sets and includes a mobile app for training and remote support, helping cardiac surgery programs reduce retained blood syndrome, postoperative atrial fibrillation, and ICU length of stay.

Koya Medical develops the Dayspring® active compression system, a portable device designed to provide dynamic compression therapy for patients with lymphedema and venous diseases. This technology enhances mobility while delivering effective treatment, addressing the limitations of traditional compression methods.

Laplace Interventional is developing a Transcatheter tricuspid valve replacement (TTVR) system for patients with Tricuspid Regurgitation. This investigational device is designed to deliver a prosthetic valve percutaneously, avoiding open-heart surgery. The goal is to potentially improve the quality of life and increase life expectancy for affected patients.

Nectero Medical is developing the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST®) System, which delivers a proprietary mixture directly to mid-sized abdominal aortic aneurysms to stabilize their growth and reduce the risk of rupture. This treatment aims to minimize the need for major surgical interventions, allowing patients to maintain a normal lifespan without facing the complications associated with traditional endovascular repair or open surgery.

SeaStar Medical develops cell-directed extracorporeal therapies that utilize selective cytopheretic devices to mitigate hyperinflammation in critically ill patients. This technology targets and modulates key immune cells, reducing the risk of multiorgan failure and potentially decreasing dialysis dependency and ICU stay duration.

Venova Medical has developed the Velocity™ Percutaneous Arteriovenous Fistula (pAVF) System, a minimally invasive technology that creates arteriovenous fistulas for hemodialysis access with rapid maturation and minimal need for reintervention. This system addresses the high reliance on catheters for dialysis, which are associated with increased morbidity and mortality, by enabling patients to initiate treatment with a functional AVF more efficiently.

Wesper offers a non-invasive at-home sleep testing solution using a wearable patch that collects comprehensive sleep data, achieving over 95% correlation with polysomnography (PSG) results. The platform provides actionable insights through automated reports and virtual consultations, enabling individuals and healthcare providers to effectively monitor and manage sleep disorders.

The startup provides a web platform and mobile application that enables users to access and compare cash-based medical care prices from healthcare providers. This system allows employers to pay medical bills in advance, eliminating out-of-pocket costs for employees while fostering competitive pricing among providers.

Zeto offers a wireless, dry electrode EEG headset designed for hospital use, eliminating the need for gel application and extensive preparation. This technology enables rapid and efficient brain activity monitoring, improving patient comfort and streamlining clinical workflows.